Active specific immunotherapy of cancer metastasis

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) A61K 35/64 (2006.01) A61K 38/19 (2006.01) A61K 39/00 (2006.01) A61K 39/39 (2006.01) A61P 35/04 (2006.01) C07H 21/02 (2006.01) C07K 1/00 (2006.01)

Patent

CA 2502960

The present invention provides for the treatment of a subject with occult brain metastasis. The treatment relies on administering to the subject a composition comprising an immunomodulatory polypeptide and a baculovirus- insect cell preparation. This composition has a unique ability to generate an anti-tumor immune response that is able to cross the blood-brain barrier.

L'invention concerne le traitement de la métastase occulte du cerveau, qui consiste à administrer une composition renfermant un polypeptide immunomodulateur et une préparation de baculovirus-cellule d'insecte. Cette composition a la capacité unique de produire une réponse immunitaire antitumorale capable de franchir la barrière hémato-encéphalique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Active specific immunotherapy of cancer metastasis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Active specific immunotherapy of cancer metastasis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Active specific immunotherapy of cancer metastasis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1768565

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.